October 18, 2022 – Mayo Clinic will launch a new Mayo Clinic Proceedings expansion journal on digital health, with the first issue to be published in early 2023. Articles will be published ahead of issue as they are accepted.
The journal, Mayo Clinic Proceedings: Digital Health, will focus on the digital transformation that is reshaping health care. It will join Mayo Clinic Proceedings: Innovations, Quality & Outcomes, an open-access journal edited by Taimur Sher, M.B.B.S., M.D., a Mayo Clinic hematologist and oncologist, that publishes the latest research on health care delivery.
The inaugural editor-in-chief of Mayo Clinic Proceedings: Digital Health is Francisco Lopez-Jimenez, M.D., co-director of Artificial Intelligence (AI) in Cardiology and chair of the Division of Preventive Cardiology at Mayo Clinic in Rochester.
Mayo Clinic Proceedings: Digital Health will focus on translation, implementation and adaptation of digital health solutions, with a particular interest in applications and real-life validations. As part of its innovative approach, the journal will go outside the standard scientific paper format and cover groundbreaking case studies, implementation examples, and disruptive methods.
Mayo Clinic Proceedings: Digital Health will be a digital-only, peer-reviewed journal. The journal will cover the broad field of digital health, with original articles, reviews, editorials and commentary on issues such as:
- AI and machine learning
- Informatics
- Telemedicine
- Electronic health records
- Virtual reality and extended reality
- Platform care
- Wearables
- Mobile technology
- Innovation in research methodology in digital health
- Regulatory issues
- Ethics
- Health equity in the digital world
- Entrepreneurship
- Commercialization
The manuscript submission process will use Editorial Manager, and the journal will be hosted on a custom website and on Elsevier’s ScienceDirect platform. Dr. Lopez-Jimenez welcomes inquiries about submitting articles to the new journal.
The journal is aiming for an international audience and will be of special interest to researchers and academicians working in medicine, biomechanical engineering, computer sciences, bioinformatics, population health, preventive medicine, mobile technology and nanoscience.